VaccImmune Europe ApS: Financial statements 2019
CVR: 39564432
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
VaccImmune Europe ApS (CVR 39564432) has filed annual accounts for 2019. In 2019, the company reported a net result of DKK -11,931. Equity in the 2019 report amounted to DKK -17,537.
- Profit/Loss
- DKK -11,931
- Equity
- DKK -17,537
- Total Assets
- DKK 1
- Employees
- 0
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
VaccImmune Europe ApS has published its interim report for the period May 1, 2018 to December 31, 2018.
As of March 6, 2019, Per Horn is registered as adm. dir. of VaccImmune Europe ApS.
As of March 6, 2019, Morten Albrechtsen has stepped down as adm. dir. of VaccImmune Europe ApS.
About VaccImmune Europe ApS
VaccImmune Europe ApS was a Danish company of the type Anpartsselskab based in Nivå, founded in 2018. The company has been dissolved on 17 November 2021. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company was previously named VaccImmune Europe IVS. According to the 2020 annual report, the company had an average of 0 employees. In 2020, the company reported a net result of DKK 17,538 compared with DKK -11,931 the year before. Equity in the 2020 report amounted to DKK 1.
